SERBIA EIB – VACCINE MANUFACTURING PLANT EXPANSION
April 1st, 2006
STORIES BY KEITH NUTHALL
THE EUROPEAN Investment Bank (EIB) has drawn up plans to lend Serbia's Torlak Institute for Virology and Immunology Euro 18 million to upgrade and expand its Belgrade production and research facilities. This will focus on selected vaccine production lines, bringing them up to international manufacturing standards, including building a new influenza vaccine production facility.
ENDS
THE EUROPEAN Investment Bank (EIB) has drawn up plans to lend Serbia's Torlak Institute for Virology and Immunology Euro 18 million to upgrade and expand its Belgrade production and research facilities. This will focus on selected vaccine production lines, bringing them up to international manufacturing standards, including building a new influenza vaccine production facility.
ENDS
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.